Out of an abundance of caution, because it is a new treatment modality, I got a retina scan done to look for any evidence of maculopathy. There was none - the opthalmologists comment was “it looks very young and healthy” (I just turned 56).
My lifetime burden of PPS, after three courses of iPPS, is about 6 g, far less than the 2.2 kg in this study. There should be no concern about retinal maculopathy.
Out of an abundance of caution, because it is a new treatment...
-
- There are more pages in this discussion • 657 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.0¢ | $63.43K | 270.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 213534 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 76890 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |